Article Details

Analysts Anticipate Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) to Announce -$0.40 EPS

Retrieved on: 2021-03-05 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

Analysts Anticipate Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) to Announce -$0.40 EPS. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 115,800 shares of the biopharmaceutical company's stock valued at $360,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up